Diabetes and Endocrinology Topic Homepage

Type 2 Diabetes

,

This educational resource contains a range of content developed for healthcare professionals based in Europe who are involved in the treatment and management of type 2 diabetes mellitus. In this section you will find:

Type 2 Diabetes Mellitus Knowledge Centre Provides prevalence statistics, treatment options, current diagnostic criteria from WHO and ADA and a section containing the latest guidelines.

Therapy Focus Compiles material on emerging insulin/incretin treatment combinations arranged across five informative sections.

‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ CME EACCME-accredited CME activity consisting of three modules and worth 1 European CME credit (ECMEC).

Type 1 Childhood Diabetes CME

,Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial well-being of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC) and should be able to:

  • Describe the psychosocial factors that can affect metabolic control
  • Discuss the rationale and clinical guideline recommendations for psychosocial screening in childhood diabetes
  • Explain the importance of family interactions and dynamics in diabetes management
  • Assess the different behavioural and psychological interventions for optimising diabetes management in children and adolescents

Centro de Experiencia

,

El Centro de Experiencia Jardiance▼® (Empagliflozina)* proporciona información sobre el uso de Jardiance.

Jardiance está indicado como medicamento adicional en el tratamiento de la diabetes mellitus tipo 2 en pacientes adultos cuando en combinación con otros medicamentos hipoglucemiantes, junto con la dieta y el ejercicio, no proporcionen un control glucémico adecuado. También está indicado como monoterapia en pacientes adultos en los que el uso de metformina se considere inapropiado debido a una intolerancia.

Los usuarios encontraran cuatro videos de expertos analizando el uso de inhibidores de SGLT2 centrándose en:

  • El paciente adecuado
  • Seguridad
  • Posición recomendada en el escalón terapéutico
  • Mecanismo de acción

*Este contenido es de tipo promocional, esponsorizado por Boehringer Ingelheim y Lilly.

†▼Este medicamento está sujeto a seguimiento adicional, es prioritaria la notificación de sospechas de reacciones adversas a este medicamento

Obesity CME series

,Obesity series

This EACCME-accredited obesity CME series contains three CME modules, which are ideal for healthcare professionals looking to improve their understanding of obesity as a serious medical illness.

Module 1 – Understanding Obesity
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy.

Module 2 – Considerations for Individualising Pharmacotherapy
Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care.

Module 3 – Rationale for Lifelong Behaviour Change
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy.

Upon successful completion of these modules, participants will receive a combined total of five European CME credits (ECMECs).

Anti-Infectives Knowledge Network CDI

,AIKN CDI

The Anti-Infectives Knowledge Network – Clostridium difficile infections (AIKN-CDI), an initiative by Astellas Pharma EMEA, shares the expertise and experience of thought leaders in the area of anti-infectives.

Recent content updates include:

  • Presentation slides from recent congresses including ECCMID, EBMT and ISICEM 2015
  • News articles from key industry thinkers located within the ‘CDI perspectives’ section
  • An animation sequence showing gut microflora and the effects of antibiotics on CDI
  • Opportunity to participate in the second round of the largest ever clinician consensus report through completing a questionnaire. Subsequent recommendations will be made based on the data collected from this questionnaire

Please remember to return often to read updated news, clinical insights, and essential information from the latest congresses.

May 2015 MYC/15/0020/EUb

Latest News

Blog

Diabetes care is a hot topic in medicine since it touches so many primary care settings; from maternity to foot care, Diabetes has multiple other pathologies. When does Diabetes care necessitate the role of a specialist? How can diabetologists ensure they work innovatively and make the patient's healthcare journey as seamless as possible? Dr. Partha Kar dives in, asking how healthcare professionals can make positive change to patients with Diabetes in Britain's NHS.

Medical Videos

An Overview of Pancreatic NET and the Available Treatments
An Overview of Pancreatic NET and the Available Treatments
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
The Cause of Obesity
The Cause of Obesity
Diabetic Macular Edema
Diabetic Macular Edema
Peter Attia: What if we're wrong about diabetes?
Peter Attia: What if we're wrong about diabetes?
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas

Recent Drug Updates

Medical Journal Abstracts on Diabetes and Endocrinology

Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)

9 days ago -  Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)

Aims: To investigate the pharmacodynamics, efficacy and safety of empagliflozin as adjunct to insulin in patients with type 1 diabetes. Methods: A total of 75 patients with glycated ...

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Thu 16 Jul 2015 -  Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and ...

Clinical Guidelines

Management of osteoporosis and the prevention of fragility fractures

Mar 2015

This guideline provides recommendations based on current evidence for best practice in the..

... management of osteoporosis and prevention of fractures. It addresses risk factors for fracture, commonly-used tools for assessment of fracture risk, approaches to targeting therapy, pharmacological, and non-pharmacological treatments to reduce fracture risk, treatment of painful vertebral fractures and systems of care. The assessment and prevention of falls is excluded as it was covered by a national resource published by NHS Quality Improvement Scotland in 2010, which aimed to prevent fractures in older people by raising the profile of falls,1and also a clinical guideline published by the National Institute for Health and Care Excellence (NICE) in 2013.2 The guideline also excludes issues surrounding the surgical management of fractures and postoperative care of patients with fractures.

This guideline will be of interest to rheumatologists, endocrinologists, general practitioners (GPs), physicians involved in care of the elderly, orthopaedic surgeons, gynaecologists, specialist nurses involved in the care of patients with osteoporosis and pharmacists.

Guidelines on Male Hypogonadism

Mar 2015

Androgens play a crucial role in the development and maintenance of male reproductive and sexual..

... functions. Low levels of circulating androgens can cause disturbances in male sexual development, resulting in congenital abnormalities of the male reproductive tract. Later in life, this may cause reduced fertility, sexual dysfunction, decreased muscle formation and bone mineralisation, disturbances of fat metabolism, and cognitive dysfunction. Testosterone levels decrease as a process of ageing: signs and symptoms caused by this decline can be considered a normal part of ageing. However, low testosterone levels are also associated with several chronic diseases, and symptomatic patients may benefit from testosterone treatment. This document presents the European Association of Urology (EAU) guidelines on diagnosis and treatment of male hypogonadism. This guideline aims to provide practical recommendations on how to deal with primary low testosterone and ageing-related decline in testosterone in male patients, as well as the treatment of testosterone disruption and deficiencies caused by other illnesses.

Online CME

Considerations for Individualising Pharmacotherapy

Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care. EACCME accredited.

Understanding Obesity

Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy....

Individual Patient Management in Type 1 Childhood Diabetes

In this EACCME-accredited online CME activity healthcare professionals will learn how to assess the psychosocial well-being of young patients with type 1 diabetes.

Clinical Trials

User Performance Evaluation of Contour Plus, Accu-Chek Active, Accu-Chek Performa and OneTouch Select Simple Blood Glucose Monitoring Systems Following ISO 15197:2013

Mon 01 Jun 2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance ...

Non-Alcoholic Fatty Liver Disease in Gestational Diabetes

Mon 11 May 2015

The thought is that Non-Alcoholic Fatty Liver Disease (NAFLD) plays a key role in the progression to prediabetes/T2DM in those with a history of Gestational Diabetes (GDM). The ...

Back to top